Syndax Pharmaceuticals, Inc. (SNDX) Financials

NASDAQ Currency in USD Disclaimer

$13.07

south_east -$0.24 (-1.8%)
Day's range
$12.91
Day's range
$13.32

SNDX Income statement / Annual

Last year (2023), Syndax Pharmaceuticals, Inc.'s total revenue was $0.00, and the percentage change from the previous year is not available. In 2023, Syndax Pharmaceuticals, Inc.'s net income was -$209.36 M. See Syndax Pharmaceuticals, Inc.�s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015 FY-2014
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Operating Revenue $0.00 $0.00 $139.71 M $1.52 M $1.52 M $1.52 M $2.11 M $1.22 M $627,000.00 $0.00
Cost of Revenue $12,000.00 $454,000.00 $456,000.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Gross Profit -$12,000.00 -$454,000.00 $139.25 M $1.52 M $1.52 M $1.52 M $2.11 M $1.22 M $627,000.00 $0.00
Gross Profit Ratio 0 0 1 1 1 1 1 1 1 0
Research and Development Expenses $163.03 M $118.50 M $88.25 M $50.44 M $42.99 M $60.11 M $48.20 M $31.67 M $9.55 M $10.18 M
General & Administrative Expenses $0.00 $33.26 M $25.24 M $22.51 M $16.06 M $17.29 M $15.86 M $13.32 M $11.59 M $11.16 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $66.92 M $33.26 M $25.24 M $22.51 M $16.06 M $17.29 M $15.86 M $13.32 M $11.59 M $11.16 M
Other Expenses $0.00 $2.42 M -$1.29 M -$1.74 M $1.49 M $1.92 M $1.15 M -$706,000.00 -$37,000.00 $4,000.00
Operating Expenses $229.95 M $151.76 M $113.49 M $72.94 M $59.06 M $77.39 M $64.06 M $44.99 M $21.14 M $21.33 M
Cost And Expenses $229.95 M $151.76 M $113.49 M $72.94 M $59.06 M $77.39 M $64.06 M $44.99 M $21.14 M $21.33 M
Interest Income $21.16 M $5.87 M $403,000.00 $841,000.00 $1.57 M $0.00 $0.00 $0.00 $161,000.00 $0.00
Interest Expense $208,000.00 $3.14 M $1.90 M $2.36 M $1.57 M $1.94 M $1.42 M $956,000.00 $1.58 M $0.00
Depreciation & Amortization $12,000.00 $454,000.00 $456,000.00 $515,000.00 $451,000.00 $78,000.00 $76,000.00 $89,000.00 $21,000.00 $15,000.00
EBITDA -$229.94 M -$151.76 M $27.28 M -$70.29 M -$55.60 M -$73.88 M -$61.88 M -$43.68 M -$20.49 M -$21.32 M
EBITDA Ratio 0 0 0.19 -47.08 -37.93 -50.02 -29.39 -35.87 -32.48 0
Operating Income Ratio 0 0 0.19 -47.08 -37.93 -50.02 -29.39 -35.87 -32.72 0
Total Other Income/Expenses Net $20.59 M $2.42 M -$1.29 M -$1.74 M $1.49 M $1.92 M $1.15 M -$706,000.00 -$3.61 M $1.50 M
Income Before Tax -$209.36 M -$149.34 M $24.93 M -$73.16 M -$56.05 M -$73.96 M -$60.80 M -$44.47 M -$24.12 M -$19.83 M
Income Before Tax Ratio 0 0 0.18 -48.23 -36.95 -48.75 -28.84 -36.45 -38.47 0
Income Tax Expense $0.00 -$5.59 M -$43,000.00 -$89,000.00 -$92,000.00 $1.92 M -$76,000.00 -$89,000.00 $1.54 M -$1.50 M
Net Income -$209.36 M -$143.75 M $24.93 M -$73.07 M -$55.96 M -$73.96 M -$60.80 M -$44.47 M -$24.12 M -$19.83 M
Net Income Ratio 0 0 0.18 -48.17 -36.89 -48.75 -28.84 -36.45 -38.47 0
EPS -2.98 -2.37 0.48 -1.77 -1.84 -2.92 -2.9 -3.04 -1.39 -2.07
EPS Diluted -2.98 -2.37 0.46 -1.77 -1.84 -2.92 -2.9 -3.04 -1.39 -2.07
Weighted Average Shares Out $70.37 M $60.76 M $52.06 M $41.31 M $30.49 M $25.37 M $21.00 M $14.62 M $17.37 M $9.60 M
Weighted Average Shares Out Diluted $70.37 M $60.76 M $53.62 M $41.31 M $30.49 M $25.37 M $21.00 M $14.62 M $17.37 M $9.60 M
Link